Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Analysis of the CD8+ T cell anti-HIV activity in heterologous cell co-cultures reveals the benefit of multiple HLA class I matches.

Killian MS, Teque F, Sudhagoni R.

Immunogenetics. 2018 Feb;70(2):99-113. doi: 10.1007/s00251-017-1021-7. Epub 2017 Jul 22.

PMID:
28735348
2.

The CD8+ cell non-cytotoxic antiviral response affects RNA polymerase II-mediated human immunodeficiency virus transcription in infected CD4+ cells.

Blazek D, Teque F, Mackewicz C, Peterlin M, Levy JA.

J Gen Virol. 2016 Jan;97(1):220-4. doi: 10.1099/jgv.0.000326. Epub 2015 Oct 23.

3.

Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection.

Ye L, Wang J, Beyer AI, Teque F, Cradick TJ, Qi Z, Chang JC, Bao G, Muench MO, Yu J, Levy JA, Kan YW.

Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9591-6. doi: 10.1073/pnas.1407473111. Epub 2014 Jun 9.

4.

Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.

Venditto VJ, Wieczorek L, Molnar S, Teque F, Landucci G, Watson DS, Forthal D, Polonis VR, Levy JA, Szoka FC Jr.

Clin Vaccine Immunol. 2014 Aug;21(8):1086-93. doi: 10.1128/CVI.00320-14. Epub 2014 May 28.

5.

CD8(+) lymphocytes suppress human immunodeficiency virus 1 replication by secreting type I interferons.

Killian MS, Teque F, Walker RL, Meltzer PS, Killian JK.

J Interferon Cytokine Res. 2013 Nov;33(11):632-45. doi: 10.1089/jir.2012.0067. Epub 2013 Feb 12.

6.

Nevirapine inhibits the anti-HIV activity of CD8+ cells.

Liu L, Wang L, Huang L, Siu V, Teque F, Aweeka FT, Levy JA.

J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):184-8. doi: 10.1097/QAI.0b013e318289822d.

7.

Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state.

Kaushik S, Teque F, Patel M, Fujimura SH, Schmidt B, Levy JA.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):501-10. doi: 10.1089/AID.2012.0200. Epub 2013 Jan 15.

8.

Transfection optimization for primary human CD8+ cells.

Liu L, Johnson C, Fujimura S, Teque F, Levy JA.

J Immunol Methods. 2011 Sep 30;372(1-2):22-9. doi: 10.1016/j.jim.2011.06.026. Epub 2011 Jul 18.

9.

No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected.

Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, Hackett J Jr, Qiu X, Luk KC, Schochetman G, Knox A, Kogelnik AM, Levy JA.

Science. 2011 Jul 1;333(6038):94-7. doi: 10.1126/science.1204963. Epub 2011 May 31.

10.

Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells.

Killian MS, Johnson C, Teque F, Fujimura S, Levy JA.

J Virol. 2011 Feb;85(4):1696-705. doi: 10.1128/JVI.01120-10. Epub 2010 Dec 8.

Supplemental Content

Support Center